NCT07690761
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07690761
Title Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant (Rituximab+ Zan)
Acronym Rituximab+ Zan
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bnai Zion Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR


No variant requirements are available.